BIO (June 2025)/ XFTTBIOCMEGL / CME EMini
BIO- - | Chg. - | Open | High | Low | Previous Close |
---|---|---|---|---|---|
-USD | - | - | - | - | - |
GlobeNewswire
5/10
Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives
GlobeNewswire
5/9
Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights
GlobeNewswire
5/9
US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire
5/8
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
GlobeNewswire
5/7
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Los...
GlobeNewswire
5/7
BIO-key Wins Coveted Global InfoSec Award for Multi-factor Authentication During RSA Conference 2024
GlobeNewswire
5/7
Palisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq Ru...
GlobeNewswire
5/7
ROSEN, NATIONAL TRIAL COUNSEL, Encourages bluebird bio Inc. Investors to Secure Counsel Before Impor...
GlobeNewswire
5/4
ROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Inquire About Securities C...
GlobeNewswire
5/2
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., ...
GlobeNewswire
5/2
Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
GlobeNewswire
5/1
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Blue
GlobeNewswire
5/1
Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives
GlobeNewswire
5/1
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merge...
GlobeNewswire
5/1
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merge...
GlobeNewswire
5/1
G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
GlobeNewswire
4/30
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of...
GlobeNewswire
4/30
BLUE LOSS ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire ...
GlobeNewswire
4/30
Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated...